Tag Archives: administration agreement

Xtandi, Bayh-Dole, and how Pfizer might stop worrying and love the march in

The American Prospect has an interesting piece (“A Big Miss on Drug Prices”) on the NIH yet again defying the Bayh-Dole Act and refusing to launch an investigation into whether UCLA and Pfizer have met Bayh-Dole’s standard (35 USC 201(f)) … Continue reading

Posted in Bayh-Dole | Tagged , , , , | Comments Off on Xtandi, Bayh-Dole, and how Pfizer might stop worrying and love the march in